[Metabolism and pharmacokinetics of lanatosides in man].
作者信息
Rietbrock N, Abshagen U
出版信息
Dtsch Med Wochenschr. 1973 Jan 19;98(3):117-22. doi: 10.1055/s-0028-1106760.
PMID:4684137
Abstract
摘要
相似文献
1
[Metabolism and pharmacokinetics of lanatosides in man].
Dtsch Med Wochenschr. 1973 Jan 19;98(3):117-22. doi: 10.1055/s-0028-1106760.
2
Letter: The double peak in the plasma-drug curve after oral digoxin and lanatoside C.
Lancet. 1973 Dec 1;2(7840):1267-8. doi: 10.1016/s0140-6736(73)91010-6.
3
[Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man].[人用H3-地高辛和H3-毛花苷丙的药代动力学研究]
Arzneimittelforschung. 1973 Jan;23(1):64-74.
4
[Pharmacokinetic principles of dosage in digitalis administration: a study on human subjects].
Schweiz Med Wochenschr. 1970 Dec 12;100(50):2163-4.
5
Non-equivalence of digoxin tablets.
Ann Clin Res. 1974;6(0):suppl 11:4-8.
6
[Behavior of cardiac glycosides in human organism. A review based on the example of digoxin and lanatoside C].
Ther Umsch. 1971 Apr;28(4):205-11.
7
[Comparative study of blood serum concentrations of digoxin and lanatoside C after single oral administration].
Wiad Lek. 1979 Sep 15;32(18):1277-81.
8
Evaluation of digoxin bioavailability in single-dose studies.
N Engl J Med. 1973 Sep 27;289(13):651-4. doi: 10.1056/NEJM197309272891302.
9
Pharmacokinetics of digitalis glycosides.洋地黄苷类的药代动力学
Drugs. 1974;7(6):482-5. doi: 10.2165/00003495-197407060-00006.
10
Bioavailability of digoxin: what the clinician needs to know.
Conn Med. 1974 May;38(5):230-2.
引用本文的文献
1
Disease-related alterations in cardiac glycoside disposition.心脏苷类药物处置的疾病相关改变。
Clin Pharmacokinet. 1982 Sep-Oct;7(5):434-51. doi: 10.2165/00003088-198207050-00004.
2
Formation and disposition of bis- and monoglycosides after administration of 3H-4'''-methyldigoxin to man.人体给予3H-4'''-甲基地高辛后双糖苷和单糖苷的形成与分布。
Eur J Clin Pharmacol. 1974;7(3):177-81. doi: 10.1007/BF00560378.
3
Beta-methyl-digoxin. VII. Tissue distribution, positive inotropic and central action in cats in comparison with other digitalis glycosides.β-甲基地高辛。VII. 与其他洋地黄苷相比，猫体内的组织分布、正性肌力作用及中枢作用
Naunyn Schmiedebergs Arch Pharmacol. 1974;286(2):195-210. doi: 10.1007/BF00501612.
4
Isomerisation of beta-acetyldigoxin in a buffered alkaline solution.
Naunyn Schmiedebergs Arch Pharmacol. 1973;279(4):413-6. doi: 10.1007/BF00500806.
5
Metabolism of digoxigenin, digoxigeninmonodigitoxoside and digoxigeninbisdigitoxoside in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1973;276(2):157-66. doi: 10.1007/BF00501188.
6
Serum digoxin concentration and half-life in newborn.
Klin Wochenschr. 1976 Apr 15;54(8):389-90. doi: 10.1007/BF01469795.
7
Disposition of beta-methyldigoxin in man.β-甲基地高辛在人体内的处置
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):105-14. doi: 10.1007/BF00614005.
8
A solid phase radioimmunoassay for digoxin and its acylated derivatives.
Naunyn Schmiedebergs Arch Pharmacol. 1975;287(3):309-19. doi: 10.1007/BF00501476.
9
[Cardiac effects and glycoside concentrations in serum and urine after oral administration of beta-methy-digoxin to healthy individuals (author's transl)].
Klin Wochenschr. 1975 Jun 1;53(11):529-33. doi: 10.1007/BF01468758.
10
Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses.多次口服和静脉给药后β-甲基地高辛的生物利用度和药代动力学
Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):373-9. doi: 10.1007/BF00606551.
Zotero 插件